These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33040178)

  • 21. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.
    Kondreddy VK; Kamatham AN
    Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS; Watson AJ; Sheng H; Helou R; Shao J; DuBois RN
    Cancer Res; 2000 Nov; 60(21):6045-51. PubMed ID: 11085526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
    Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
    Yang P; Cartwright C; Chan D; Ding J; Felix E; Pan Y; Pang J; Rhea P; Block K; Fischer SM; Newman RA
    Mol Carcinog; 2014 Jul; 53(7):566-77. PubMed ID: 23371504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
    D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
    Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
    Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
    J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance.
    Poorani R; Bhatt AN; Dwarakanath BS; Das UN
    Eur J Pharmacol; 2016 Aug; 785():116-132. PubMed ID: 26335394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines.
    Dommels YE; Haring MM; Keestra NG; Alink GM; van Bladeren PJ; van Ommen B
    Carcinogenesis; 2003 Mar; 24(3):385-92. PubMed ID: 12663496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
    Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
    Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
    Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX-2 inhibitors and metabolism of essential fatty acids.
    Das UN
    Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin potentiates the anti-inflammatory activity of cyclooxygenase inhibitors in the cotton pellet granuloma pouch model.
    Nandal S; Dhir A; Kuhad A; Sharma S; Chopra K
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):89-93. PubMed ID: 19455263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
    Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
    Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
    Lu S; Obianom ON; Ai Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
    Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.